Clinical trial Recruiting at 2 sites Interventional Ages 18 to 40

Augmented Reality Binocular Therapy for Adult Amblyopia

Official title: Augmented Reality-Based Binocular Therapy for Visual Rehabilitation in Adults With Amblyopia

Run by Polytechnic Institute of Porto · NCT07819552 · Data updated 2026-11-12

This trial tests a home-based augmented reality binocular therapy to see if it improves vision in adults 18–40 with anisometropic amblyopia, compared with placebo training.

Quick facts

Study typeInterventional
Ages18 Years to 40 Years
SexAll
Enrollment60 (estimated)
SponsorPolytechnic Institute of Porto
Academic / other
Locations2 sites (Coimbra, Coimbra District and 1 other locations)
StatusRecruiting
StartedMay 1, 2026
Main results expectedJanuary 31, 2028
Study endsJanuary 31, 2028
Registry record updatedSeptember 18, 2026
Trial IDNCT07819552 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–40 with unilateral anisometropic amblyopia (interocular BCVA difference ≥2 lines and worse-eye BCVA ≤20/32).

Probably not a fit

Individuals with amblyopia other than anisometropic, bilateral amblyopia, or other ocular/neuro-ophthalmic conditions may not benefit from this therapy.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with anisometropic amblyopia will use a mixed-reality headset at home to perform binocular visual training designed to encourage both eyes to contribute. Participants are randomly assigned to active AR binocular therapy or placebo AR visual training, with the same device used in both groups. The study will assess improvements in visual acuity, binocular function, and potential changes in retinal and brain function, plus whether gains persist at 6 months post-treatment.

Why it matters

Potential benefit: If successful, the therapy could improve visual acuity and binocular vision in adults with anisometropic amblyopia and offer a convenient home-based treatment option.

How similar studies have gone: Previous binocular/dichoptic approaches have shown promise in adults, though home-based AR implementations are relatively novel and require confirmation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 18 and 40 years.
* Diagnosis of anisometropic amblyopia, defined as unilateral amblyopia with an interocular difference of at least 2 lines in best-corrected visual acuity (BCVA), with BCVA worse than 20/32 in the more affected eye.

Exclusion Criteria:

* Amblyopia other than anisometropic amblyopia.
* Bilateral amblyopia.
* Ophthalmologic or neuro-ophthalmologic disease other than amblyopia.
* Neurological disease, chronic pharmacological therapy, or implanted medical devices.
* Any ocular surgery or ocular treatment within the previous year.
* Significant media opacities that may prevent fundus examination.
* Inability to provide informed consent.

Where it's running

  • Coimbra Institute for Biomedical Imaging and Translational Research (CIBIT), University of Coimbra
    Coimbra, Coimbra District, Portugal
    Recruiting
  • RISE-Health, Center for Translational Health and Medical Biotechnology Research (TBIO), School of Health, Polytechnic of Porto
    Porto, Porto District, Portugal
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.